Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Reforms At Crossroads: Will User Fee Momentum Reach Critical Mass?

This article was originally published in The Gray Sheet

Executive Summary

Device user fee advocates have a window of opportunity in which to capitalize on support from Senate HELP Committee leaders in pushing the proposal through Prescription Drug User Fee Act reauthorization this year

You may also be interested in...



Tauzin Will Tackle Device Reforms Outside PDUFA; Eshoo Urges Hearings

House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization

Device User Fees On The Table For PDUFA III: Senate Cmte. In Discussions

Senate Health, Education, Labor & Pensions (HELP) Committee staffers are actively considering device user fee language for inclusion in the Prescription Drug User Fee Act reauthorization this year

HIMA LOBBYING IN SUPPORT OF DEVICE USER FEE BILL

HIMA LOBBYING IN SUPPORT OF DEVICE USER FEE BILL is focused on key members of the House and Senate committees that will consider the measure. The Health Industry Manufacturers Association is attempting to persuade opponents of the bill, introduced July 12, not to set up obstacles to its passage, arguing that if the measure fails Congress could end up adopting legislation that is less friendly to industry.

UsernamePublicRestriction

Register

LL1134940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel